BioCentury
ARTICLE | Finance

Evans rumors abound

Rumored newco from Christopher Evans seeking investors, pharma partners

October 31, 2011 7:00 AM UTC

Rumors have been bubbling up about Sir Christopher Evans, whose Excalibur Group has not disclosed an investment since 2008. Leaked details from early investor pitches suggest the Excalibur chairman is raising a significant amount of cash for newco NCPharma Inc.

The last disclosed investment by Excalibur's Merlin Biosciences Funds was a £2.5 million ($4.9 million) convertible loan facility for stem cell company ReNeuron Group plc (LSE:RENE). The last large investment came in 2006 as part of a $35 million series B round for ophthalmic company Neurotech Pharmaceuticals Inc...